[Federal Register Volume 66, Number 125 (Thursday, June 28, 2001)]
[Notices]
[Page 34456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-16196]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


General and Plastic Surgery Devices Panel of the Medical Devices 
Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: General and Plastic Surgery Devices Panel of the 
Medical Devices Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on July 17, 2001, 10 a.m. 
to 5 p.m.
    Location: Hilton, Salons D and E, 620 Perry Pkwy., Gaithersburg, 
MD.
    Contact: David Krause, Center for Devices and Radiological Health 
(HFZ-410), Food and Drug Administration, 9200 Corporate Blvd., 
Rockville, MD 20850, 301-594-3090, ext. 141, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12519. Please call the Information Line or access the 
Internet address of http://www.fda.gov/cdrh/panelmtg.html for up-to-
date information on this meeting.
    Agenda: The committee will discuss, make recommendations, and vote 
on a premarket approval application for an interactive wound and burn 
bressing. Background information, including the agenda and questions 
for the committee, will be made available to the public on July 16, 
2001, on the Internet at http://www.fda.gov/cdrh/panelmtg.html.
    Procedure: On July 17, 2001, from 10:30 a.m. to 5 p.m., the meeting 
is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
July 3, 2001. Oral presentations from the public will be scheduled 
between approximately 11 a.m. and 11:30 a.m., and between approximately 
3 p.m. and 3:30 p.m. Time allotted for each presentation may be 
limited. Those desiring to make formal oral presentations should notify 
the contact person before July 3, 2001, and submit a brief statement of 
the general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication of 
the approximate time requested to make their presentation.
    Closed Committee Deliberations: On July 17, 2001, from 10 a.m. to 
10:30 a.m., the meeting will be closed to permit FDA to present to the 
committee trade secret and/or confidential commercial information (5 
U.S.C. 552b(c)(4)) relating to pending issues and applications.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: June 19, 2001.
Bonnie Malkin,
Special Assistant to the Senior Associate Commissioner.
[FR Doc. 01-16196 Filed 6-27-01; 8:45 am]
BILLING CODE 4160-01-S